Compare BLIN & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLIN | OSRH |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 12.5M |
| IPO Year | 2007 | N/A |
| Metric | BLIN | OSRH |
|---|---|---|
| Price | $0.99 | $0.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.62 | N/A |
| AVG Volume (30 Days) | 79.6K | ★ 10.2M |
| Earning Date | 12-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,375,000.00 | N/A |
| Revenue This Year | $2.68 | N/A |
| Revenue Next Year | $16.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.54 | N/A |
| 52 Week Low | $0.90 | $0.45 |
| 52 Week High | $2.80 | $12.54 |
| Indicator | BLIN | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 39.89 | 45.41 |
| Support Level | $0.98 | $0.63 |
| Resistance Level | $1.12 | $0.77 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 31.53 | 1.00 |
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.